☆ 4.7 Review

Utilization of Food-Derived β-Glucans to Prevent and Treat Non-Alcoholic Fatty Liver Disease (NAFLD)

FOODS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Gastroenterology & Hepatology

The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review

Zobair M. Younossi et al.

Summary: A comprehensive meta-analysis was conducted to assess the global and regional prevalence, incidence, and mortality of non-alcoholic fatty liver disease (NAFLD). The results showed that the global prevalence of NAFLD is 30% and increasing, highlighting the need for urgent and comprehensive strategies to raise awareness and address NAFLD on local, regional, and global levels.

HEPATOLOGY (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis

Jingxuan Quek et al.

Summary: This study provides an overview of the global prevalence of NAFLD, NAFL, and NASH in overweight and obese individuals. The findings show that the prevalence of NAFLD in the overweight population is 69.99%, NAFL is 42.49%, and NASH is 33.50%. These results contribute to a better understanding of the global burden of NAFLD and support disease management in the at-risk overweight and obese population.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Article Biochemistry & Molecular Biology

Extraction, characterization, and anti-nonalcoholic steatohepatitis activity of a (1,3) (1,6)-?-D-glucan from the Polyporus umbellatus (Pers.) Fries

Wei Gao et al.

Summary: Nonalcoholic steatohepatitis (NASH) is a chronic liver disease characterized by inflammation and hepatic steatosis that may coincide with fibrotic activity. A purified beta-glucan compound (PUP-W-1) from Polyporus umbellatus was found to prevent the development of NASH in a murine steatohepatitis model by suppressing inflammation, lipid accumulation, and fibrosis. These findings suggest that PUP-W-1 holds promise as a natural drug candidate or precursor for NASH treatment.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Changing epidemiology, global trends and implications for outcomes of NAFLD

Vincent Wai-Sun Wong et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease globally, affecting approximately 38% of the global population. Although only a minority of patients progress to severe complications, the number of patients at risk for such outcomes is increasing. Factors such as changes in dietary composition, urbanization, obesity, and type 2 diabetes contribute to the increasing prevalence of NAFLD. However, there are significant geographical variations in NAFLD and non-alcoholic steatohepatitis (NASH) prevalence rates, which can be attributed to socioeconomic and genetic factors.

JOURNAL OF HEPATOLOGY (2023)

添加到收藏夹

Review Biochemistry & Molecular Biology

Challenges and opportunities in NASH drug development

Stephen A. Harrison et al.

Summary: This Review provides an overview of the challenges and potential solutions in clinical trials for NASH drugs, emphasizing the need for non-invasive tests and biomarkers to replace invasive liver biopsies as primary endpoints. While NAFLD and NASH are prevalent worldwide, no approved drugs are available currently. The histopathological assessment of liver biopsies, currently required for drug approval, presents a major challenge due to its variability, leading to high screen-failure rates. Non-invasive tests correlating with liver histology and outcomes show promise but require further validation for regulatory endorsement in phase 3 trials.

NATURE MEDICINE (2023)

添加到收藏夹

Review Gastroenterology & Hepatology

Circadian regulation of liver function: from molecular mechanisms to disease pathophysiology

Nityanand Bolshette et al.

Summary: This review discusses the impact of the circadian clock on liver homeostasis and its association with liver-related diseases such as nonalcoholic fatty liver disease, type 2 diabetes mellitus, and hepatocellular carcinoma. The liver circadian clock regulates various liver functions and is influenced by the circadian control from other organs, cells, microbiome, and immune cells in the gastrointestinal tract. Disruption of the circadian system, due to factors like jetlag, shift work, or unhealthy lifestyle, is implicated in metabolic diseases and liver malignancies. The review highlights the role of circadian dysregulation in the development and progression of liver pathologies and discusses therapeutic and lifestyle interventions to support a functional circadian clock.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

添加到收藏夹

Article Nutrition & Dietetics

Effects of β-glucan, probiotics, and synbiotics on obesity-associated colitis and hepatic manifestations in C57BL/6J mice

Vuong Vu et al.

Summary: This study showed that modulating gut bacteria with beta-glucan and probiotics improved obesity-associated colitis, with synbiotics having a stronger and broader effect compared to individual treatments. Synbiotics were able to promote the growth of both indigenous and supplemented probiotic strains, resulting in improved gut health.

EUROPEAN JOURNAL OF NUTRITION (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease

Yuanqiang Ma et al.

Summary: This review summarizes the relationship between oxidative stress and the development of nonalcoholic fatty liver disease (NAFLD), and discusses the potential role of antioxidants as therapeutic agents for NAFLD.

ANTIOXIDANTS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Lentinan Protects against Nonalcoholic Fatty Liver Disease by Reducing Oxidative Stress and Apoptosis via the PPARα Pathway

Tingyi Du et al.

Summary: This study shows that Lentinan (LNT) can ameliorate hepatic steatosis, decrease oxidative stress and apoptosis by activating the PPAR alpha pathway, providing a potential drug target for NAFLD.

METABOLITES (2022)

添加到收藏夹

Review Chemistry, Multidisciplinary

Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease

Ting-ying Jiao et al.

Summary: Nonalcoholic fatty liver disease (NAFLD), characterized by lipid accumulation in liver cells, has become the primary cause of chronic liver diseases worldwide. The progression of NAFLD to nonalcoholic steatohepatitis (NASH) is strongly related to multiple metabolic disorders and diseases. Disturbances in bile acid metabolism play a significant role in NASH pathogenesis, and bile acid receptors are considered attractive targets for NASH treatment.

ACTA PHARMACOLOGICA SINICA (2022)

添加到收藏夹

Review Food Science & Technology

Effect of β-glucan on metabolic diseases: a review from the gut microbiota perspective

Chunhua Chen et al.

Summary: Dietary intervention in regulating gut microbiota can improve the pathophysiological indicators and gut health of metabolic diseases. This review focuses on the effects of (3-glucan on the development of metabolic diseases and the role of gut microbiota in modulating these diseases.

CURRENT OPINION IN FOOD SCIENCE (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Hepatoprotective Effects of Aureobasidium pullulans Derived ? 1,3-1,6 Glucans in a Murine Model of Non-alcoholic Steatohepatitis

Nobunao Ikewaki et al.

Summary: This study evaluated the potential of AFO-202 and N-163 beta-glucans as anti-fibrotic and anti-inflammatory hepatoprotective agents in a NASH animal model. The results showed that AFO-202 significantly reduced inflammation-associated hepatic cell ballooning and steatosis, while N-163 significantly decreased fibrosis and inflammation. The combination of AFO-202 with N-163 significantly decreased the NAFLD Activity Score.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut-Liver Axis

Xiang Chen et al.

Summary: NAFLD is the most common chronic liver disease affecting global public health at present, and there is a lack of research on its mechanism and therapeutic strategy. The gut-liver axis theory has gradually disclosed the association between polysaccharides and the protective role in NAFLD by affecting multiple interrelated levels such as gut microbiota, metabolites regulation, and intestinal barrier function.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Review Immunology

The contribution of the gut-liver axis to the immune signaling pathway of NAFLD

Jiayi Liu et al.

Summary: NAFLD, the liver manifestation of metabolic syndrome, involves various factors such as metabolic disturbances, inflammation, and cell death. The intestinal-liver axis theory suggests a close relationship between changes in intestinal flora and the development of NAFLD, affecting pathways like energy metabolism to regulate the pathogenesis of NAFLD.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Two unique biological response-modifier glucans beneficially regulating gut microbiota and faecal metabolome in a non-alcoholic steatohepatitis animal model, with potential applications in human health and disease

Senthilkumar Preethy et al.

Summary: The study showed a significant increase in gut microbial diversity in the AFO-202+N-163 group, along with changes in beneficial faecal metabolites, indicating potential benefits for both the nervous system and metabolic conditions.

BMJ OPEN GASTROENTEROLOGY (2022)

添加到收藏夹

Review Chemistry, Applied

Insights on ß-glucan as a prebiotic coadjuvant in the treatment of diabetes mellitus: A review

Katia Sivieri et al.

Summary: The prevalence of Diabetes Mellitus and type 2 diabetes (T2D) is increasing worldwide. Diet plays a key role in the reversion of dysbiosis reported in T2D patients. Beta-glucans, found in certain cereals, yeasts, and mushrooms, have shown potential in modulating glucose homeostasis. However, research on the influence of beta-glucans on biochemical markers and gut microbiota is limited.

FOOD HYDROCOLLOIDS FOR HEALTH (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Highland barley β-glucan alleviated western diet-induced non-alcoholic fatty liver disease via increasing energy expenditure and regulating bile acid metabolism in mice

Huicui Liu et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is a growing public health burden, and controlling bile acids (BAs) metabolism and energy expenditure may be potential therapies. Cereal beta-glucan (BG) has shown to regulate imbalances in BAs metabolism, prevent fat accumulation, and increase energy expenditure in NAFLD mice.

FOOD & FUNCTION (2022)

添加到收藏夹

Article Medicine, General & Internal

Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy

Alberto Ferrarese et al.

Summary: NASH cirrhosis has become a rapidly growing indication for liver transplantation at Padua University Hospital, with good post-transplant survival.

MEDICINA-LITHUANIA (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Nonalcoholic Steatohepatitis Is the Most Rapidly Increasing Indication for Liver Transplantation in the United States

Zobair M. Younossi et al.

Summary: Based on data analysis from the 2019 Scientific Registry of Transplant Recipients, NASH was the second most common indication for liver transplantation in 2019 and the fastest increasing indication. In 2019, NASH was the leading indication for liver transplantation among women without HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Modeling dysbiosis of human NASH in mice: Loss of gut microbiome diversity and overgrowth of Erysipelotrichales

James K. Carter et al.

Summary: The study characterized the microbiome in a well-validated murine NASH model and identified substantial remodeling of the intestinal microbiome in NASH mice, with declines in species diversity and bacterial abundance. The Western Diet was found to be the primary driver of early changes to the microbiome, leading to loss of diversity within the first week. Additionally, a NASH gut microbiome signature, including a reproducible bloom of the Firmicute order Erysipelotrichales, emerged progressively at weeks 6 and 12.

PLOS ONE (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease

Phillipp Hartmann et al.

Summary: ALD and NAFLD are important causes of morbidity and mortality worldwide, with the intestinal microbiota playing a crucial role in their development and progression. Treatments for ALD and NAFLD include fecal microbiota transplantation, probiotics, prebiotics, synbiotics, and antibiotics. Precision medicine approaches targeting the intestinal microbiome aim to ameliorate both diseases.

SEMINARS IN LIVER DISEASE (2021)

添加到收藏夹

Review Medicine, General & Internal

Oxidative Stress in Non-alcoholic Fatty Liver Disease. An Updated Mini Review

Anna Pia Delli Bovi et al.

Summary: This article discusses the interplay between oxidative stress and other pathogenic factors in non-alcoholic fatty liver disease (NAFLD), emphasizing the importance of reactive oxygen species (ROS) in NAFLD progression. It also points out the effectiveness of healthy diet and physical activity in NAFLD treatment, but lack of compliance, and the potential of precision medicine in selecting the best treatment for specific patients.

FRONTIERS IN MEDICINE (2021)

添加到收藏夹

Article Chemistry, Applied

Circadian disruption-induced metabolic syndrome in mice is ameliorated by oat β-glucan mediated by gut microbiota

Wai-Yin Cheng et al.

Summary: This study demonstrated that oral administration of oat beta-glucan can alleviate circadian disruption-induced metabolic syndrome by enhancing gut microbiota diversity, increasing beneficial bacterial populations, and promoting butyrate production to improve weight gain, glucose tolerance, and endocrine function.

CARBOHYDRATE POLYMERS (2021)

添加到收藏夹

Review Microbiology

Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions

Tomas Hrncir et al.

Summary: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, highly associated with metabolic syndrome. Dysbiosis of gut microbiota and disruption of intestinal permeability may play a role in its development. Therapeutic strategies include fecal microbiota transplantation, probiotics, prebiotics, and other approaches.

MICROORGANISMS (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Modeling Diet-Induced NAFLD and NASH in Rats: A Comprehensive Review

Lydie Carreres et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and research is focusing on decoding the molecular mechanisms behind it to identify new therapeutic targets. Reliable, simple, and reproducible tools are necessary for investigating these pathways, with animal models such as diet-induced NAFLD and NASH being developed to mimic the human disease. Rat models, specifically the dietary model of NAFLD and NASH, are being used to study different dietary compositions and their effects on liver pathogenesis.

BIOMEDICINES (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut-Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy

Francesca Fianchi et al.

Summary: NAFLD, the leading cause of liver disease worldwide, requires efforts in identifying pathogenetic factors and new therapeutic approaches. The gut-liver axis plays a key role in the pathogenesis of NAFLD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Agriculture, Multidisciplinary

Hepatic Lipidomics Analysis Reveals the Ameliorative Effects of Highland Barley β-Glucan on Western Diet-Induced Nonalcoholic Fatty Liver Disease Mice

Huicui Liu et al.

Summary: The study demonstrates that BG from highland barley can significantly alleviate liver steatosis induced by NAFLD, by altering lipid metabolic patterns and regulating lipid metabolism-related genes. Additionally, the research also identified 13 differentially regulated lipid species that may serve as lipid biomarkers.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

添加到收藏夹

Review Gastroenterology & Hepatology

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Agustin Albillos et al.

JOURNAL OF HEPATOLOGY (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Lower gut microbiome diversity and higher abundance of proinflammatory genus Collinsella are associated with biopsy-proven nonalcoholic steatohepatitis

Stuart Astbury et al.

GUT MICROBES (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

Rod S. Taylor et al.

GASTROENTEROLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway

Charng-Cherng Chyau et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Nutrition & Dietetics

Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan

Ming-Chao Tsai et al.

NUTRIENTS (2020)

添加到收藏夹

Review Medicine, General & Internal

Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD

Xiaofan Jiang et al.

FRONTIERS IN MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

β-Glucan ameliorates nonalcoholic steatohepatitis induced by methionine and choline-deficient diet in mice

Tianyang Huang et al.

JOURNAL OF FOOD BIOCHEMISTRY (2020)

添加到收藏夹

Article Food Science & Technology

Lactobacillus rhamnosusGG and Oat Beta-Glucan Regulated Fatty Acid Profiles along the Gut-Liver-Brain Axis of Mice Fed with High Fat Diet and Demonstrated Antioxidant and Anti-Inflammatory Potentials

Yu Fung Yau et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2020)

添加到收藏夹

Article Chemistry, Applied

A synbiotic consisting of Lactobacillus plantarum S58 and hull-less barley beta-glucan ameliorates lipid accumulation in mice fed with a high-fat diet by activating AMPK signaling and modulating the gut microbiota

Tian Tang et al.

CARBOHYDRATE POLYMERS (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease

Xinrong Zhang et al.

LIVER INTERNATIONAL (2020)

添加到收藏夹

Review Cell Biology

Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?

Patricia Rada et al.

CELL DEATH & DISEASE (2020)

添加到收藏夹

Article Endocrinology & Metabolism

Synbiotic-driven improvement of metabolic disturbances is associated with changes in the gut microbiome in diet-induced obese mice

Xinxin Ke et al.

MOLECULAR METABOLISM (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

Zobair M. Younossi et al.

JOURNAL OF HEPATOLOGY (2019)

添加到收藏夹

Correction Cell Biology

Fatty Liver Disease Caused by High-Alcohol-Producing Klebsiella pneumoniae (vol 30, pg 675, 2019)

Jing Yuan et al.

CELL METABOLISM (2019)

添加到收藏夹

Review Endocrinology & Metabolism

Gut microbial metabolites in obesity, NAFLD and T2DM

Emanuel E. Canfora et al.

NATURE REVIEWS ENDOCRINOLOGY (2019)

添加到收藏夹

Article Gastroenterology & Hepatology

Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries

Magnus Holmer et al.

LIVER INTERNATIONAL (2018)

添加到收藏夹

Article Food Science & Technology

Oat β-glucan inhibits adipogenesis and hepatic steatosis in high fat diet-induced hyperlipidemic mice via AMPK signaling

Bo Liu et al.

JOURNAL OF FUNCTIONAL FOODS (2018)

添加到收藏夹

Review Biochemistry & Molecular Biology

A critical review on the impacts of beta-glucans on gut microbiota and human health

Muthukumaran Jayachandran et al.

JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Botryosphaeran reduces obesity, hepatic steatosis, dyslipidaemia, insulin resistance and glucose intolerance in diet-induced obese rats

Amadeu Z. Silva et al.

LIFE SCIENCES (2018)

添加到收藏夹

Article Gastroenterology & Hepatology

The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics

Glenn R. Gibson et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)

添加到收藏夹

Review Cell Biology

Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification

Matthew R. Panasevich et al.

PHYSIOLOGICAL GENOMICS (2017)

添加到收藏夹

Review Endocrinology & Metabolism

Treatment of nonalcoholic fatty liver disease: role of AMPK

Brennan K. Smith et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Nonalcoholic Fatty Liver Disease Pathophysiology and Management

Rotonya M. Carr et al.

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota

Jerome Boursier et al.

HEPATOLOGY (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Giulio Marchesini et al.

JOURNAL OF HEPATOLOGY (2016)

添加到收藏夹

Article Multidisciplinary Sciences

Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

Marialena Mouzaki et al.

PLOS ONE (2016)

添加到收藏夹

Article Gastroenterology & Hepatology

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Paul Angulo et al.

GASTROENTEROLOGY (2015)

添加到收藏夹

Review Biochemistry & Molecular Biology

Biological activities of derivatized D-glucans: A review

Francini Yumi Kagimura et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)

添加到收藏夹

Review Medicine, General & Internal

Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

Erin K. Spengler et al.

MAYO CLINIC PROCEEDINGS (2015)

添加到收藏夹

Article Medicine, Research & Experimental

Effect of polycan, a β-glucan originating from Aureobasidium, on a high-fat diet-induced hyperlipemic hamster model

Mee-Kyoung Lim et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Oral administration of the Aureobasidium pullulans-derived β-glucan effectively prevents the development of high fat diet-induced fatty liver in mice

Shiho Aoki et al.

SCIENTIFIC REPORTS (2015)

添加到收藏夹

Article Medicine, General & Internal

Nonalcoholic fatty liver disease

Elizabeth M. Brunt et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

添加到收藏夹

Article Gastroenterology & Hepatology

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

Colin Hill et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

Yoshihisa Takahashi et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

添加到收藏夹

Article Gastroenterology & Hepatology

Fecal Microbiome and Volatile Organic Compound Metabolome in Obese Humans With Nonalcoholic Fatty Liver Disease

Maitreyi Raman et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

添加到收藏夹

Article Integrative & Complementary Medicine

Beta-Glucan-Rich Extract from Pleurotus sajor-caju (Fr.) Singer Prevents Obesity and Oxidative Stress in C57BL/6J Mice Fed on a High-Fat Diet

G. Kanagasabapathy et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

添加到收藏夹

Article Agriculture, Multidisciplinary

Comparative Proteome Analysis of Bifidobacterium longum subsp infantis Grown on β-Glucans from Different Sources and a Model for Their Utilization

Jinyang Zhao et al.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2013)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice

Shuiping You et al.

FOOD & FUNCTION (2013)

添加到收藏夹

Article Food Science & Technology

Prebiotic potential of barley derived β-glucan at low intake levels: A randomised, double-blinded, placebo-controlled clinical study

Evdokia K. Mitsou et al.

FOOD RESEARCH INTERNATIONAL (2010)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.